GENE ONLINE|News &
Opinion
Blog

Conference
Gene and Cell Therapies in Focus at ASGCT 2025: Tackling Rare Diseases, Autoimmune Conditions, and More
2025-05-14
Genespire Presents Promising Preclinical Data on Liver-Directed Gene Therapy for MMA at ASGCT 2025
2025-05-14
Discover Investment Opportunities & Innovation at International Healthcare Week in Hong Kong from May
2025-05-12
Swiss Biotech Day 2025 Showcases Global Growth, Innovation, and Collaboration in Biotechnology
2025-05-09
ASGH and Hong Kong International Medical Fair 2025 Set to Transform Healthcare Landscape
2025-05-08
Taiwan’s BPIPO and DCB Drive Regenerative Medicine Development with Japan’s Industry Leaders in Tokyo
2025-05-06
AI-Driven Model Enhances Cancer Cachexia Prediction by Integrating Imaging and Clinical Data
2025-05-02
AI-Based Model Accurately Classifies Pediatric Sarcomas Using Digital Pathology Images
2025-04-30
Taiwan’s BPIPO and DCB Join Japan’s LINK-J and FIRM for First Regenerative Medicine Investment Forum in Tokyo
2025-04-29
Study Shows ctDNA Liquid Biopsy Detects Colorectal Cancer Recurrence Earlier Than Imaging
2025-04-29
Senti Biosciences to Showcase New Cell & Gene Therapy Data at AACR Annual Meeting 2025
2025-04-27
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Unlocking the Gut Code: Japan’s Pharmaceutical Sector Explores the Future of Microbiome Therapeutics
2025-04-23
SABPA Hosts 9th Frontiers in Therapeutics and Diagnostics Forum in San Diego
2025-04-14
SABPA OC/LA’s 17th Annual Biomedical Forum: Innovation and Industry Leaders Unite in Irvine, CA on April 26, 2025
2025-03-13
1 2 3
LATEST
Tirzepatide Users See 20.2% Average Weight Loss in Obesity Management Trial
2025-05-14
iMMagine-1 Phase 2 Study Provides Data on Investigational Matter Characteristics and Behavior
2025-05-14
Novo Nordisk Partners with Septerna in $2.2 Billion Deal to Develop Oral Obesity Drugs
2025-05-14
Emrelis Approved for Advanced NSCLC Patients with High c-Met Overexpression
2025-05-14
Reshema Kemps-Polanco of Novartis US Named 2025 HBA Woman of the Year
2025-05-14
Reshema Kemps-Polanco of Novartis US Named 2025 HBA Woman of the Year
2025-05-14
Eli Lilly Ranks First in Overall Drug Development; AstraZeneca Leads in Pharmaceutical Invention, Consultancy Report Finds
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top